Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
TAK-243 for Leukemia
Recruiting1 awardPhase 1
Toronto, Ontario
This trial is testing a new drug called TAK-243 to see what dose is safe and what side effects it may cause in patients with certain types of blood cancer that has come back or is not
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service